[Skip to Navigation]
Sign In
News From the Food and Drug Administration
March 20, 2018

Smart Watch Detects Seizures

JAMA. 2018;319(11):1086. doi:10.1001/jama.2018.1809

The first smart watch used to monitor seizures has received FDA approval. Marketed under the name Embrace, the watch uses advanced machine learning to detect grand mal or generalized tonic-clonic seizures and to alert a caregiver for help.

The technology senses movement and electrical fluctuations in the skin that may be associated with seizures in people who have epilepsy. When a seizure is detected, the watch sends a command to a paired wireless device that’s programmed to alert a designated caregiver. The watch records and stores data that a health care professional can review. The device also analyzes sleep, rest, and physical activity. It was approved last year in Europe as a seizure-monitoring medical device.

Add or change institution